Delivery Order SPE2DB22D1017-SPE2DB25FF9DV
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,237.14, is for the delivery of RYTARY ER 23.75 MG-95 MG capsules, a medication used in the treatment of Parkinson's disease. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 2, 2025. This award is not associated with a set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,194.28, is for the delivery of RYTARY ER (extended-release) capsules, which are used to treat Parkinson's disease. This is a firm fixed-price delivery order contract with a completion date of May 8, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $9,452.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RYTARY ER 23.75 MG-95 MG capsules, a medication used in the treatment of Parkinson's disease. The contract has an ultimate completion date of October 31, 2023 and is structured as a firm fixed price delivery order. There was no set-aside requirement for this award. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,313.68 firm fixed price delivery order is for the supply of RYTARY ER 23.75 MG-95 MG capsules, a medication used to treat Parkinson's disease. The contract has a completion date of November 13, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $11,792.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rytary ER 48.75 mg-195 mg capsules, a medication used in the treatment of Parkinson's disease. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $2,161.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range...
This federal contract award, valued at $11,748.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG capsules, a prescription medication. The award is a delivery order against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,733.90, is for the provision of RYTARY ER 48.75 MG-195 MG capsules, a medication used to treat Parkinson's disease. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,975.98, is for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a wide range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024. The contract has a firm fixed price of $2,359.95 and an ultimate completion date of December 31, 2024. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules, a medication used in the treatment of Parkinson's disease. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...